FI48930C - Menetelmä 3-(5-nitro-2-furyyli)-2-isoksatsoliinien uusien terapeuttise sti aktiivisten johdannaisten valmistamiseksi. - Google Patents

Menetelmä 3-(5-nitro-2-furyyli)-2-isoksatsoliinien uusien terapeuttise sti aktiivisten johdannaisten valmistamiseksi.

Info

Publication number
FI48930C
FI48930C FI682252A FI225268A FI48930C FI 48930 C FI48930 C FI 48930C FI 682252 A FI682252 A FI 682252A FI 225268 A FI225268 A FI 225268A FI 48930 C FI48930 C FI 48930C
Authority
FI
Finland
Prior art keywords
isoxazolines
furyl
nitro
preparation
therapeutically active
Prior art date
Application number
FI682252A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI48930B (enrdf_load_html_response
Inventor
William Hoyle
Graham Arton Howarth
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of FI48930B publication Critical patent/FI48930B/fi
Publication of FI48930C publication Critical patent/FI48930C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI682252A 1967-08-26 1968-08-09 Menetelmä 3-(5-nitro-2-furyyli)-2-isoksatsoliinien uusien terapeuttise sti aktiivisten johdannaisten valmistamiseksi. FI48930C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3935167 1967-08-26

Publications (2)

Publication Number Publication Date
FI48930B FI48930B (enrdf_load_html_response) 1974-10-31
FI48930C true FI48930C (fi) 1975-02-10

Family

ID=10409082

Family Applications (1)

Application Number Title Priority Date Filing Date
FI682252A FI48930C (fi) 1967-08-26 1968-08-09 Menetelmä 3-(5-nitro-2-furyyli)-2-isoksatsoliinien uusien terapeuttise sti aktiivisten johdannaisten valmistamiseksi.

Country Status (18)

Country Link
US (1) US3769295A (enrdf_load_html_response)
JP (1) JPS4827310B1 (enrdf_load_html_response)
AT (1) AT277221B (enrdf_load_html_response)
BE (1) BE719891A (enrdf_load_html_response)
CA (1) CA933926A (enrdf_load_html_response)
CH (1) CH502372A (enrdf_load_html_response)
CS (1) CS157037B2 (enrdf_load_html_response)
DE (1) DE1795208A1 (enrdf_load_html_response)
DK (1) DK118820B (enrdf_load_html_response)
ES (1) ES357511A1 (enrdf_load_html_response)
FI (1) FI48930C (enrdf_load_html_response)
FR (2) FR1589115A (enrdf_load_html_response)
GB (1) GB1234213A (enrdf_load_html_response)
IE (1) IE32300B1 (enrdf_load_html_response)
NL (2) NL6811722A (enrdf_load_html_response)
NO (1) NO125931B (enrdf_load_html_response)
SE (1) SE330540B (enrdf_load_html_response)
YU (1) YU199068A (enrdf_load_html_response)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915978A (en) * 1970-01-07 1975-10-28 Merck & Co Inc Nitroimidazoles
US4010176A (en) * 1972-10-27 1977-03-01 Merck & Co., Inc. Isoxazole substituted nitroimidazoles
US4109002A (en) * 1976-06-14 1978-08-22 Eli Lilly And Company Fungicidal 3-phenyl-5-(substituted methyl) isoxaxoles
US4203994A (en) * 1976-06-14 1980-05-20 Eli Lilly And Company Fungicidal 3-phenyl-5-(substituted methyl)isoxazoles
IL85691A0 (en) * 1987-04-10 1988-08-31 Pennwalt Corp 5-(phenyl or phenoxymethyl)-3-(2-furanyl or 2-thienyl)-3-(1h-imidazol-1-ylmethyl)-2-methylisoxazolidines and salts thereof
DE69716925T2 (de) * 1996-08-21 2003-09-11 Pharmacia & Upjohn Co., Kalamazoo Isoxazoline derivate und ihre verwendung als antimikroben
DK1054874T3 (da) * 1998-02-13 2002-12-30 Upjohn Co Substituerede aminophenylisoxazolinderivater, der er anvendelige som antimokrobielle midler
CA2318762A1 (en) * 1998-02-25 1999-09-02 Richard Charles Thomas Substituted aminomethyl isoxazoline derivatives useful as antimicrobials
EP1349853B1 (en) * 2000-12-21 2006-03-08 Pharmacia & Upjohn Company LLC Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
JP2005512975A (ja) * 2001-10-25 2005-05-12 アストラゼネカ アクチボラグ 抗菌薬として有用なイソキサゾリン誘導体
ATE323087T1 (de) * 2001-10-25 2006-04-15 Aryl substituierte oxazolidinone mit antibacterieller activität
CN101774976B (zh) * 2010-01-26 2012-05-09 天津药物研究院 磺酰基异噁唑啉衍生物及抗肿瘤用途
CN101781294B (zh) * 2010-03-10 2012-02-01 天津药物研究院 一类咪唑的衍生物、其制备方法和用途
CA2977919A1 (en) * 2015-02-27 2016-09-01 Op Bio Factory Co., Ltd. Method for producing kakeromycin and derivatives thereof

Also Published As

Publication number Publication date
CA933926A (en) 1973-09-18
FR8102M (enrdf_load_html_response) 1970-07-27
ES357511A1 (es) 1970-03-16
IE32300L (en) 1969-02-26
DK118820B (da) 1970-10-12
NL6811722A (enrdf_load_html_response) 1969-02-28
YU199068A (en) 1978-05-15
CS157037B2 (enrdf_load_html_response) 1974-08-23
DE1795208A1 (de) 1972-03-16
AT277221B (de) 1969-12-10
IE32300B1 (en) 1973-06-13
SE330540B (enrdf_load_html_response) 1970-11-23
NL137326C (enrdf_load_html_response)
FI48930B (enrdf_load_html_response) 1974-10-31
FR1589115A (enrdf_load_html_response) 1970-03-23
GB1234213A (enrdf_load_html_response) 1971-06-03
JPS4827310B1 (enrdf_load_html_response) 1973-08-21
CH502372A (de) 1971-01-31
US3769295A (en) 1973-10-30
BE719891A (enrdf_load_html_response) 1969-02-24
NO125931B (enrdf_load_html_response) 1972-11-27

Similar Documents

Publication Publication Date Title
FI49957C (fi) Menetelmä terapeuttisesti vaikuttavien oksiimieetterien valmistamiseks i.
FI42712C (fi) Menetelmä terapeuttisesti vaikuttavien bifenyylialkaanijohdannaisten valmistamiseksi
DK128353B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive bis-chromoner.
FI49300C (fi) Menetelmä terapeuttisesti aktiivisten 1,4-dihydropyridiinijohdannaiste n valmistamiseksi.
FI49497C (fi) Menetelmä terapeuttisesti vaikuttavien 1-fenoksi-2-3-alkyyliaminopropa anien valmistamiseksi.
FI50707C (fi) Menetelmä uusien farmakologisesti vaikuttavien hydroksisykloheksyyliam iinien valmistamiseksi.
FI48930C (fi) Menetelmä 3-(5-nitro-2-furyyli)-2-isoksatsoliinien uusien terapeuttise sti aktiivisten johdannaisten valmistamiseksi.
FI49958C (fi) Menetelmä terapeuttisesti aktiivisen aminoguanidiini-johdannaisen valm istamiseksi.
FI49720C (fi) Menetelmä terapeuttisesti vaikuttavien 2-metyyli-3-karbonihappoamidoki noksaliini-di-N-oksidien-(1,4) valmistamiseksi.
FI46960C (fi) Menetelmä terapeuttisesti aktiivisten imidatsolijohdannaisten valmista miseksi
FI52857C (fi) Menetelmä terapeuttisesti vaikuttavien amidoksiimien valmistamiseksi.
FI48083C (fi) Menetelmä uusien, terapeuttisesti aktiivisten imidatsolijohdannaisten valmistamiseksi
FI44801C (fi) Menetelmä uusien, terapeuttisesti vaikuttavien, emäksisten eettereiden valmistamiseksi.
DK117635B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 3-(piperazinoalkyl)-pyrazoler.
FI49718C (fi) Menetelmä terapeuttisesti vaikuttavien 2-halogeenimetyyli-3-karbonihap poamidokinoksaliini-di-N-oksidien-(1,4) valmistamiseksi.
FI50420C (fi) Menetelmä terapeuttisesti aktiivisten 4-pyrimidinyyli-1,4-dihydropyrid iinijohdannaisten valmistamiseksi
FI48576C (fi) Menetelmä terapeuttisesti aktiivisten alfa-fluori-malonihappojohdannai sten valmistamiseksi.
FI50879C (fi) Menetelmä terapeuttisesti vaikuttavien substituoitujen 3-aminoasyyliam ino-tiofeenien valmistamiseksi.
FI48190C (fi) Menetelmä terapeuttisesti aktiivisten 10alfa-metoksi-9,10-dihydroergol iinijohdannaisten valmistamiseksi
FI48842C (fi) Menetelmä farmakologisesti aktiivisten 6-kloori-1H-2,3-bentsoksatsiini en valmistamiseksi.
FI47661C (fi) Menetelmä terapeuttisesti vaikuttavien bentsofuraanijohdannaisten valm istamiseksi.
FI46066C (fi) Analogiamenetelmä terapeuttisesti vaikuttavien N,N-dimetyyliamino-etyy li-14beta-hydroksi-5beta-pregn-20-eeni-21-karboksylaattien valmistamis eksi.
FI47357C (fi) Menetelmä terapeuttisesti vaikuttavien 4'-demetyyli-epipodofyllotoksii ni-beta-D-glukosidin johdannaisten valmistamiseksi.
FI49038C (fi) Analogiamenetelmä uusien, farmakologisesti aktiivisten 4-fenyyli-1H-ki natsoliini-2-oni-johdannaisten valmistamiseksi.
FI48841C (fi) Menetelmä farmakologisesti aktiivisten 5-nitro-2-furfuryylideeniamino- oksatsolidinonien valmistamiseksi.